This symposium series aims to provide a platform for promising biotech startup companies to highlight their science and share their stories in building a fledgling business in Seattle.

Symposium Agenda

8:30 – 8:40 AM PT
PBSS Welcome and Overview
Shichang Miao, PhD, President, PBSS; Peter Korytko, Chair, PBSS Seattle 

---

8:40 – 9:15 AM PT
Engineering the Next Wave of Bispecific Therapeutics Through Cell Surface Proximity Biology
Pamela Holland, PhD, Senior Vice President of Biology, InduPro Therapeutics

---

9:15 – 9:50 AM PT
Biotech’s Holy Grail: How Lumen Bioscience has Pioneered Oral Biologic Drugs
Brian Finrow, JD, Chief Executive Officer, Lumen Bioscience

---

9:50 – 10:25 AM PT
Allogeneic g-NK Cells for the Treatment of Cancer and Autoimmune Disease
Mark Frohlich, MD, Chief Executive Officer, Indapta Therapeutics

---

10:25 – 10:35 AM PT
Break

---

10:35 – 11:10 AM PT
Daiad Technology: Re-engineering Potent Immune Agonists to Widen the Therapeutic Index
Jonathan Drachman, MD, Chief Executive Officer, StradBio

---

11:10 – 11:45 AM PT
What Makes Washington a Top Global Hub for Life Sciences Innovation?
Marc Cummings, MS, President and Chief Executive Officer, Life Science Washington

---

11:45 AM – 12:20 PM PT
Panel Discussion, Q&A, and Symposium Conclusion
All Speakers

For more information and to register, visit the site here.

Featured Speakers

🔹 Mark Frohlich, MD
Chief Executive Officer, Indapta Therapeutics
Presentation: Indapta Therapeutics – Building the Future of Allogeneic Cell Therapy

🔹 Pamela Holland, PhD
Senior Vice President of Biology, InduPro Therapeutics
Presentation: InduPro Therapeutics – Advancing Precision Therapeutics Through Induced Proximity

🔹 Brian Finrow, JD
Founder, Chief Executive Officer & Chairman, Lumen Bioscience
Presentation: Lumen Bioscience – From Innovative Science to Commercial Impact

🔹 Jonathan Drachman, MD
Chief Executive Officer & Co-Founder, StradBio, Inc.
Presentation: StradBio – Transforming Drug Discovery Through Computational Biology

🔹 Marc Cummings, MS
President & Chief Executive Officer, Life Science Washington
Presentation: Building Washington State’s Life Sciences Ecosystem